Clinical and pathological outcomes of nephrectomy/metastasectomy in patients with metastatic renal cell carcinoma after prior immune checkpoint inhibitor exposure

被引：0
|
作者：
Amaral, Paulo Siqueira
Beckermann, Katy
Hillis, Mikala
Schaffer, Kerry Roe
Ancell, Kristin Kathleen
Lambrecht, Morgan
Kaiser, Elizabeth
Rini, Brian I.
机构：
[1] Vandebilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16515
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
    Martini, Dylan J.
    Olsen, T. Anders
    Goyal, Subir
    Liu, Yuan
    Evans, Sean T.
    Magod, Benjamin
    Brown, Jacqueline T.
    Yantorni, Lauren
    Russler, Greta Anne
    Caulfield, Sarah
    Goldman, Jamie M.
    Nazha, Bassel
    Kissick, Haydn T.
    Harris, Wayne B.
    Kucuk, Omer
    Carthon, Bradley C.
    Master, Viraj A.
    Bilen, Mehmet Asim
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] CYTOREDUCTIVE NEPHRECTOMY IS ASSOCIATED WITH IMPROVED SURVIVAL FOR SARCOMATOID METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED BEFORE OR AFTER SURGERY WITH IMMUNE CHECKPOINT INHIBITORS
    Paz, Lotan
    Jose, A. Karam
    Viraj, A. Master
    Philippe, E. Spiess
    Charles, C. Peyton
    Sarah, P. Psutka
    Jay, D. Raman
    Chiara, Mercinelli
    Edouard, Nicalse
    Nicholas, D. Robertson
    Barry, Sirard R.
    Amber, Jani
    Manley, Wade J.
    Brandon, Manley
    Dattatraya, Patil
    Glenn, O. Allen
    Surena, F. Matin
    Jason, Abel E.
    Daniel, D. Shapiro
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [43] Real-world evidence of the impact of prior antibiotic exposure on immune checkpoint inhibitor outcomes in patients with metastatic urothelial cancer
    Hoffman-Censits, Jean H.
    Harshman, Lauren Christine
    Metcalf, Meredith
    Abou Alaiwi, Sarah
    Meyer, Craig S.
    Yang, Erru
    Satram, Sacha
    Ogale, Sarika
    Faber, Kathleene
    Ma, Esprit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [44] The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma
    Hall, Bryan D. R.
    Abel, Edwin Jason
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (03) : 379 - +
  • [45] Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma
    Singla, Nirmish
    Elias, Roy
    Ghandour, Rashed A.
    Freifeld, Yuval
    Bowman, Isaac A.
    Rapoport, Leonid
    Enikeev, Mikhail
    Lohrey, Jay
    Woldu, Solomon L.
    Gahan, Jeffrey C.
    Bagrodia, Aditya
    Brugarolas, James
    Hammers, Hans J.
    Margulis, Vitaly
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (12) : 924 - 931
  • [46] COMPREHENSIVE IMMUNOGENOMIC EVALUATION OF PATIENTS UNDERGOING CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT BLOCKADE
    Stephen, Reese
    Vijay, Yarlagadda
    Chih-Ying, Wu
    Fengshen, Kuo
    Cerise, Tang
    Hui, Jiang
    Vuong, Lynda H.
    Lennert, Eismann
    Robert, Motzer
    Voss, Martin H.
    Victor, Reznik Ed Reuter
    Johnathan, Coleman
    Paul, Russo
    Kotecha, Ritesh R.
    Christina, Leslie
    Yingbei, Chen
    Ari, Hakimi A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S44 - S44
  • [47] COMPREHENSIVE IMMUNOGENOMIC EVALUATION OF PATIENTS UNDERGOING CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT BLOCKADE
    Reese, Stephen
    Yarlagadda, Vijay
    Wu, Chih-Ying
    Kuo, Fengshen
    Tang, Cerise
    Jiang, Hui
    Dawidek, Mark
    Vuong, Lynda H.
    Eismann, Lennert
    Motzer, Robert
    Reznik, Ed
    Reuter, Victor S.
    Coleman, Johnathan S.
    Russo, Paul S.
    Kotecha, Ritesh R.
    Leslie, Christina S.
    Chen, Yingbei
    Hakimi, A. Ari S.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1071 - E1071
  • [48] Clinical outcomes of tyrosine kinase inhibitors immediately after immune checkpoint inhibitors in renal cell carcinoma
    Kato, Taigo
    Nagahara, Akira
    Kawamura, Norihiko
    Nakata, Wataru
    Soda, Tetsuji
    Matsuzaki, Kyousuke
    Hatano, Koji
    Kawashima, Atsunari
    Ujike, Takeshi
    Nishimura, Kensaku
    Takada, Shingo
    Tsujihata, Masao
    Yamaguchi, Seiji
    Takao, Tetsuya
    Nakai, Yasutomo
    Nakayama, Masashi
    Uemura, Motohide
    Nonomura, Norio
    ANNALS OF ONCOLOGY, 2022, 33 : S497 - S497
  • [49] Safety and feasibility of nephrectomy after receipt of immune checkpoint inhibitors for renal cell carcinoma.
    Singla, Nirmish
    Elias, Roy
    Ghandour, Rashed
    Freifeld, Yuval N.
    Bowman, Alex Isaac
    Woldu, Solomon L.
    Gahan, Jeffrey
    Bagrodia, Aditya
    Brugarolas, James
    Hammers, Hans J.
    Margulis, Vitaly
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [50] A MULTICENTER ASSESSMENT OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) WHO RECEIVED IMMUNE CHECKPOINT INHIBITOR THERAPY (ICI) WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN)
    Gross, Evan
    Li, Mingjia
    Yin, Ming
    Orcutt, Delaney
    Hussey, Duncan
    Trott, Elliot
    Kramer, Joel
    Oliva, Kaylee
    Gore, John
    Schade, George
    Lin, Daniel
    Tykodi, Scott
    Hall, Evan
    Thompson, John
    Parikh, Anish
    Yang, Yuanquan
    Collier, Katharine
    Miah, Abdul
    Mori-Vogt, Sherry
    Hinkley, Megan
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Clinton, Steven
    Psutka, Sarah
    JOURNAL OF UROLOGY, 2021, 206 : E255 - E255
12345